Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 45 | BSPED2016 | Next issue

44th Meeting of the British Society for Paediatric Endocrinology and Diabetes

ea0045p11 | CME | BSPED2016

Early administration of asfotase alfa in a newborn with perinatal hypophosphatasia

Chinoy Amish , Mughal Zulf , Padidela Raja

Hypophosphatasia (HPP) is an inherited systemic metabolic bone disease occurring due to mutations in the ALPL gene which encodes for tissue-nonspecific alkaline phosphatase (TNSALP), resulting in defective bone mineralisation due to accumulation of inorganic pyrophosphate (PPi). The perinatal form of this condition lays at the most severe end of the spectrum. Enzyme replacement therapy with asfotase alfa, a recombinant fusion protein that includes the catalytic domain...